CoChat

Shaping the Intimate: Influences on the Experience of Everyday Nerves

Healy, David · 2004 · Social Studies of Science
Cited by 131

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Before 1980, most people experiencing common nervous problems and who sought medical help complained of anxiety and were treated for anxiety. Similar experiences increasingly led to complaints of or treatment for panic attacks in the late 1980s and early 1990s, and to complaints of or treatment for mood disorders by the mid-1990s. Today, such patients seem once again increasingly likely to complain of and be treated for anxiety. This paper reviews a series of mechanisms whereby company marketing can both transform the perceptions of physicians and shape the experiences of those seeking treatment and the self-understanding of those not in treatment. These include the standard ploys of company sales departments to increase demand for products, including celebrity endorsements, the sponsoring of educational events and a host of reminders. The portfolio of marketing manoeuvres has grown, though, by translating educational events and celebrity events into the arena of scientific research: clinical trials have increasingly become part of the marketing of disorders and their treatments; ghost-written scientific papers are authored by celebrity researchers. The portfolio of marketing manoeuvres has also grown to encompass new ways of creating fashion through medical activism, by setting up patient groups and disease awareness campaigns. The result is a transformation and growth in disorders tailor-made to fit ever more visible drugs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0306312704042620

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 45

  1. 10.1097/00004583-199804000-00016 · DOI
  2. Berman, Elaine S. (1999) ‘Too Little Bone: The Medicalization of Osteoporosis’ , Journal of Woman’s Health and Law 1: 257–277 .
  3. Braithwaite, John (1986) Corporate Crime in the Pharmaceutical Industry ( London: Routledge & Kegan Paul ).
  4. De Grazia, David (2000) ‘Prozac, Enhancement and Self-creation’ , Hastings Center Report 30: 34–40 . · DOI · Paper page
  5. Edwards, James C. (2000) ‘Passion, Activity and “The Care of the Self”’ , Hastings Center Report 30: 31–33 . · DOI
  6. Elliott, Carl (2000) ‘Pursued by Happiness and Beaten Senseless’ , Hastings Center Report 30: 7–12 . · DOI
  7. 10.1016/0277-9536(91)90347-F · DOI
  8. 10.1177/026988119000400310 · DOI
  9. 10.1192/bjp.158.6.737 · DOI
  10. Healy, David (1998) The Antidepressant Era ( Cambridge, MA: Harvard University Press ).
  11. Healy, David (1999) ‘Antidepressant Psychopharmacotherapy: At the Crossroads’ , International Journal of Psychiatry in Clinical Practice 3: S9–S15 .
  12. 10.2307/3528308 · DOI
  13. 10.1192/apt.7.5.322 · DOI · Paper page
  14. Healy, David (2002a) The Creation of Psychopharmacology ( Cambridge, MA: Harvard University Press ).
  15. 10.1353/pbm.2002.0028 · DOI · Paper page
  16. 10.1159/000068691 · DOI · Paper page
  17. 10.1192/bjp.182.6.465-a22 · doi:10.1192/bjp.182.6.465-a22
  18. 10.1017/S0033291701003968 · DOI
  19. 10.1176/appi.ajp.158.9.1449 · DOI · Paper page
  20. Klein, Donald (1996) ‘Reaction Patterns to Psychotropic Drugs and the Discovery of Panic Disorder’, in D. Healy (ed.), The Psychopharmacologists, vol. 1 ( London: Arnold ): 329–352.
  21. 10.1192/bjp.161.4.465 · DOI
  22. 10.1192/bjp.160.2.191 · DOI · Paper page
  23. 10.1001/archpsyc.1989.01810070096016 · DOI
  24. 10.2307/3528307 · DOI
  25. Kuhn, T. (1962) ‘The Structure of Scientific Revolutions’ ( Chicago, IL: University of Chicago Press ).
  26. 10.1192/bjp.182.1.3 · DOI
  27. 10.1016/S0140-6736(02)08198-9 · DOI
  28. 10.1016/S0140-6736(02)08617-8 · doi:10.1016/s0140-6736(02)08617-8
  29. Latour, Bruno (1986) Science in Action: How to Follow Scientists and Engineers through Society ( Cambridge, MA: Harvard University Press ).
  30. 10.1111/1468-0009.00185 · DOI
  31. 10.1136/bmj.318.7192.1180 · DOI · Paper page
  32. 10.1001/archpsyc.1989.01810070096016 · DOI
  33. 10.1192/bjp.162.6.795 · DOI
  34. 10.1192/S0007125000035583 · DOI
  35. 10.1192/S0007125000180936 · DOI
  36. Medawar, Charles, Andrew Herxheimer, Andrew Bell & Shelley Jofre (2003) ‘Paroxetine, Panorama, and User Reporting of ADRs. Consumer Intelligence Matters in Clinical Practice and Post-Marketing Drug Surveillance’ , International Journal of Risk and Safety in Medicine 15: 161–169 . · DOI · Paper page
  37. 10.1136/bmj.324.7342.886 · DOI · Paper page
  38. Mundy A. (2001) Dispensing with the Truth ( New York: St Martin’s Press ).
  39. Murray, C.J.L. & A.D. Lopez (1996) Global Health Statistics: A Compendium of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020 ( Cambridge MA: Harvard University Press ).
  40. Rose, Nikolas (2003) ‘Becoming Neurochemical Selves’, in N. Stehr (ed.), Biotechnology between Commerce and Civil Society ( Piscataway, NJ: Transaction Publishers ).
  41. Sheahan, David (2000) ‘Angles on Panic’, in D. Healy (ed.), The Psychopharmacologists, vol. 3 ( London: Arnold ): 479–504.
  42. Shorter, Edward (2001) ‘Historical Review of Diagnosis and Treatment of Depression’, in Ann Dawson & Andre Tylee (eds), Depression: Social, and Economic Timebomb ( London: BMJ Books ): 25–30.
  43. 10.1192/bjp.162.6.788 · DOI
  44. Stecklow, S. & L. Johannes (1997) ‘Questions Arise on New Drug Testing. Drug Makers Relied on Clinical Researchers Who Now Await Trial’ , Wall Street Journal (15 August).
  45. 10.1192/bjp.178.3.234 · DOI · Paper page

Cited by

See all 131

Metadata

Authors
Healy, D.
Venue
Social Studies of Science
Published
2004-04
Volume
34
Issue
2
Pages
219-245
ISSN
  • 0036-8539 (ISSN-L)
  • 0306-3127
  • 1460-3659
OpenAlex
W2142230847
Cited by
131
References
7
FWCI
5.30
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.